Application Progress of MRI-IVIM, T1mapping and T2mapping in Diagnosis and Treatment of Breast Diseases

Xiong Zhang; Yao Zhang; Hao Xiong

doi:10.54097/pkwysa27

Authors

Xiong Zhang
Yao Zhang
Hao Xiong

DOI:

https://doi.org/10.54097/pkwysa27

Keywords:

Breast Diseases, MRI-IVIM, T1mapping, T2mapping

Abstract

This article summarizes the application progress of MRI-IVIM, T1mapping, and T2mapping techniques in the diagnosis and treatment of breast diseases. These techniques, leveraging their advantages of being non-radiative, high soft tissue resolution, and multi-functional imaging, provide significant support for the diagnosis of breast diseases. IVIM technology measures the microscopic motion of water molecules to reflect the microcirculatory perfusion of lesions; T1mapping technology measures T1 relaxation time to reveal the physical properties of tissues, aiding in distinguishing different types of breast tissue; T2mapping technology measures T2 relaxation time to reflect changes in the microscopic structure of tissues, providing sensitive indicators for early detection of breast diseases. These techniques can distinguish between benign and malignant lesions, assess the tumor microenvironment, predict breast cancer subtypes, and evaluate treatment efficacy, thus providing a basis for the selection and adjustment of treatment plans. However, these techniques also face challenges such as high costs and limited accessibility, lack of standardized data interpretation, and prolonged examination times that affect patient comfort. Future development directions will focus on the integration of technologies and multi-modal imaging, artificial intelligence and automation, and technological optimization and cost reduction, aiming to achieve personalized diagnosis and precise treatment of breast diseases, thereby improving treatment outcomes and patient quality of life.

Downloads

Download data is not yet available.

References

[1] Peng, F., Xu, H. , & Song, YuXu, KeLi, ShuhaoCai, XiaotangGuo, YingkunGong, Lianggeng. (2023). Longitudinal study of multi-parameter quantitative magnetic resonance imaging in duchenne muscular dystrophy: hyperresponsiveness of gluteus maximus and detection of subclinical disease progression in functionally stable patients. Journal of neurology, 270(3), 1439-1451.

[2] Peng, X., Ding, H. , & Huaibi HuoYue ZhengJie ZhouHan LiYang HouXiaolin LiWenqing GengHong ShangTing Liu. (2023). Editorial for "cardiac mri‐based assessment of myocardial injury in asymptomatic people living with human immunodeficiency virus: correlation with nadir cd4 count". Journal of Magnetic Resonance Imaging, 58(6), 1824-1825.

[3] Song, Y., Xu, H. Y. , Xu, K. , Guo, Y. K. , Xie, L. J. , & Peng, F. , et al. (2023). Clinical utilisation of multimodal quantitative magnetic resonance imaging in investigating muscular damage in duchenne muscular dystrophy: a study on the association between gluteal muscle groups and motor function. Pediatric Radiology, 53(8), 1648-1658.

[4] Thavendiranathan, P. , Zhang, L. , Zafar, A. , Drobni, Z. D. , & Neilan, T. G. (2021). Myocardial t1 and t2 mapping by magnetic resonance in patients with immune checkpoint inhibitor–associated myocarditis. Journal of the American College of Cardiology, 77(12), 1503-1516.

[5] Krug, K. , Burke, C. , Weiss, K. , Baltzer, P. , Rhiem, K. , & Maintz, D. , et al. (2022). Influence of aging and gadolinium exposure on t1, t2, and t2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-t brain mr imaging. European radiology, 32(1), 331-345.

[6] Tahir, E. , Azar, M. , Shihada, S. , Seiffert, K. , Goy, Y. , & Beitzen-Heineke, A. , et al. (2022). Myocardial injury detected by t1 and t2 mapping on cmr predicts subsequent cancer therapy–related cardiac dysfunction in patients with breast cancer treated by epirubicin-based chemotherapy or left-sided rt. European Radiology, 32(3), 1853-1865.

[7] Huang, S. , Gong, X. , Guan, S. , Zheng, S. , Li, F. , & Xu, Q. , et al. (2020). Clinical value of mri t2-mapping quantitative assessment of carotid plaque. Acta radiologica (Stockholm, Sweden: 1987), 61(8), 1021-1025.

[8] Bettina, Baessler, Christian, Luecke, Julia, & Lurz, et al. (2019). Cardiac mri and texture analysis of myocardial t1 and t2 maps in myocarditis with acute versus chronic symptoms of heart failure. Radiology, 292(3), 608-617.

[9] Huber, A. T, Jérme.Lamy, Bravetti, M. , Bouazizi, K. , Bacoyannis, T. , & Roux, C. , et al. (2019). Comparison of mr t1 and t2 mapping parameters to characterize myocardial and skeletal muscle involvement in systemic idiopathic inflammatory myopathy (iim). European radiology, 29(10), 5139-5147.

[10] Ewertz, M. , Land, L. H. , Dalton, S. O. , Cronin-Fenton, D. , & Jensen, M. B. (2018). Influence of specific comorbidities on survival after early-stage breast cancer. Acta Oncologica, 57(1), 129-134.

[11] He, P. , Chen, W. , Bai, M. Y. , Li, J. , Wang, Q. Q. , & Fan, L. H. , et al. (2023). Clinical application of computer-aided diagnosis system in breast ultrasound: a prospective multicenter study. World Journal of Surgery, 47(12), 3205-3213.

[12] Leem, C. , Wang, Y. , & Juhasz, K. E. (2023). Selective use of radiological staging in node‐positive stage ii breast cancer patients may have a role in treatment. ANZ journal of surgery., 93(9), 2203-2207.

[13] Ginzac, A. , Passildas, J. , Gadéa, Emilie, Abrial, C. , Molnar, I. , & Trésorier, Romain, et al. (2019). Treatment-induced cardiotoxicity in breast cancer: a review of the interest of practicing a physical activity. Oncology, 96(5), 1-12.

[14] Schairer, Catherine, Pfeiffer, Ruth, M., & Gadalla, et al. (2018). Autoimmune diseases and breast cancer risk by tumor hormone‐receptor status among elderly women. International Journal of Cancer, 142(6), 1202-1208.

[15] Nafar, S. , Tabei, S. M. B. , Nouri, N. , Alipour, M. , & Zare, F. (2022). Exosome as a target for cancer treatment. Journal of Investigative Medicine, 70(5), 1212-1218.

[16] Zhu, T. , Huang, Y. H. , Li, W. , Wu, C. G. , Zhang, Y. M. , & Zheng, X. X. , et al. (2024). A non-invasive artificial intelligence model for identifying axillary pathological complete response to neoadjuvant chemotherapy in breast cancer: a secondary analysis to multicenter clinical trial. British Journal of Cancer, 131(4), 692-701.

[17] Doblas, S. , Wagner, M. , Leitao, H. S. , Daire, J. L. , Sinkus, R. , & Vilgrain, Valérie, et al. (2018). Determination of malignancy and characterization of hepatic tumor type with diffusion-weighted magnetic resonance imaging: comparison of apparent diffusion coefficient and intravoxel incoherent motion-derived measurements. Journal of the Taiwan Institute of Chemical Engineers, 48(10), 722.

[18] A, E. G., A, Y. Y. , B, M. G. , C, C. F. , & C, Q. Z. (2020). Predicting human disease-associated circrnas based on locality-constrained linear coding. Genomics, 112(2), 1335-1342.